The global Cold Chain Products Market for Plasma Fractionation is projected to reach USD 711 million by 2027 from USD 569 million in 2022, at a CAGR of 4.5% during the forecast period. There are several factors which drive the Cold Chain Products Market for Plasma Fractionation like Rising use of immunoglobulins and other plasma products in a range of therapeutic area, Increasing demand for Plasma-derived medicinal products, and Technological advancements in refrigeration equipment and systems.
The market for Cold Chain Products Market for Plasma Fractionation is dominated by companies like B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
To know about the assumptions considered for the study download the pdf brochure
THERMO FISHER SCIENTIFIC (US)
In 2021, Thermo Fisher Scientific held an approximate major market share in the Cold chain products market for plasma fractionation. The company provides a wide range of medical refrigerators and freezers that cater to the storage and transportation requirements of plasma and fractionated compounds. Thermo Fisher Scientific has achieved a prominent position in the market through its emphasis on research and development, as well as the introduction of new products through collaborations, partnerships, and acquisitions. This strategic approach has contributed to the company's leadership in the industry.
HAIER BIOMEDICAL (HAIER GROUP) (CHINA)
Haier Biomedical, a subsidiary of Haier Group, specializes in the development, manufacturing, and marketing of high-quality laboratory equipment and refrigerated products for the life science and clinical sectors. The company is dedicated to securing its position in the global Cold Chain Products Market for Plasma Fractionation through various strategies. These include strengthening partnerships with current customers, improving operational efficiency and product quality, and expanding its product range, capabilities, and expertise. Haier Biomedical implements both organic and inorganic growth approaches, such as introducing new products, expanding its operations, acquiring relevant businesses, forming agreements and partnerships, collaborating with industry stakeholders, and divesting certain assets. These strategies enable the company to achieve its objectives and maintain a competitive position in the global Cold Chain Products Market for Plasma Fractionation.
Eppendorf SE (GERMANY)
Eppendorf SE, a prominent player in the life sciences industry, is engaged in the global development and sale of instruments, consumables, and services for handling liquids, samples, and cells in laboratories. The company offers a wide range of highly diverse products, including various types of medical freezers and refrigerators. To uphold its position in the cold chain solution segment, Eppendorf SE prioritizes innovation and continuously enhances its research and development capabilities to meet the demands of storing biological samples in cold conditions. With direct offices and subsidiaries across almost all regions worldwide, the company has established a strong presence globally. Furthermore, Eppendorf SE has made substantial investments in assets, allowing it to become a truly global company with subsidiaries on every continent. This extensive network of distribution channels and production facilities gives the company a significant competitive edge.
B Medical Systems (Azenta lifesciences) (US)
B medical systems, a leading provider of life sciences solutions, offers a diverse range of dependable solutions for cold chain sample management and genomic services. The company was acquired by Azenta, Inc., another prominent supplier of life sciences solutions specializing in reliable cold-chain sample management solutions and genomic services. B. Medical Systems' comprehensive solutions encompass vaccine cold chain management, medical refrigeration, and blood management. Their product portfolio includes cutting-edge transport systems, ultra-low freezers, solar vaccine refrigerators and freezers, laboratory freezers, laboratory refrigerators, plasma freezers, and blood bank refrigerators. The company's strategic focus on expanding its range of cold storage products through collaborations and partnerships has been instrumental in driving its growth in the market.
Cold Chain Products Market for Plasma Fractionation by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE